| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 699 |
| 1 | ADALIMUMAB | 625 |
| 2 | PREDNISONE | 327 |
| 3 | METHOTREXATE SODIUM | 317 |
| 4 | METHOTREXATE | 296 |
| 5 | ADALIMUMAB-ADAZ | 191 |
| 6 | ADALIMUMAB-AATY | 187 |
| 7 | ADALIMUMAB-FKJP | 187 |
| 8 | ETANERCEPT | 151 |
| 9 | SULFASALAZINE | 133 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 111 | 0.4237 |
| 1 | TETANUS IMMUNE GLOBULIN (HUMAN) | 12 | 0.1101 |
| 2 | ACEBUTOLOL HYDROCHLORIDE | 63 | 0.0491 |
| 3 | PRENATAL SUPPLEMENT WITH DHA | 1 | 0.0227 |
| 4 | INFLIXIMAB-DYYB | 65 | 0.0189 |
| 5 | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, .BETA.-CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM | 1 | 0.0164 |
| 6 | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 1 | 0.0114 |
| 7 | CIPAGLUCOSIDASE ALFA-ATGA | 1 | 0.0110 |
| 8 | ANAKINRA | 120 | 0.0071 |
| 9 | BOTULINUM TOXIN TYPE A | 87 | 0.0068 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 767 |
| 1 | Corticosteroid [EPC] | 394 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 296 |
| 3 | Aminosalicylate [EPC] | 212 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 160 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 130 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 128 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 120 |
| 8 | Proton Pump Inhibitor [EPC] | 107 |
| 9 | Opioid Agonist [EPC] | 99 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 120 | 0.0071 |
| 1 | Provitamin D2 Compound [EPC] | 92 | 0.0031 |
| 2 | Uric Acid-specific Enzyme [EPC] | 10 | 0.0026 |
| 3 | Aminosalicylate [EPC] | 212 | 0.0021 |
| 4 | Human Immunoglobulin G [EPC] | 39 | 0.0019 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 37 | 0.0015 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 130 | 0.0009 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 128 | 0.0009 |
| 8 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 89 | 0.0009 |